Myla P Lai-Goldman MD
Anatomic Pathology, Clinical Pathology
Co-Founder and Chairperson, GeneCentric Therapeutics
Join to View Full Profile
C/o Personalized Science, LLCBurlington, VT 05403
Dr. Lai-Goldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1989- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1988
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1983 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
CA State Medical License 1985 - 2026
NC State Medical License 1990 - 2021
NJ State Medical License 2003 - 2009
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 122 citationsLung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune LandscapeHawazin Faruki, Gregory Mayhew, Jonathan S. Serody, D. Neil Hayes, Charles M. Perou
Journal of Thoracic Oncology. 2017-06-01 - 5 citationsValidation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data SetsHawazin Faruki, Gregory Mayhew, Cheng Fan, Matthew D. Wilkerson, Scott Parker
Archives of Pathology & Laboratory Medicine. 2016-06-01 - 13 citationsApplication of a pharmacogenetic test adoption model to six oncology biomarkers.Hawazin Faruki, Myla Lai-Goldman
Personalized Medicine. 2010-07-05
Press Mentions
Precision Cancer Drug Startup GeneCentric Acquires Nearby Select ImmunoGenomicsAugust 26th, 2019- RTP-Based GeneCentric Therapeutics Seeks Better Diagnostic Test for Head, Neck CancerAugust 19th, 2019
GeneCentric Therapeutics Acquires Select ImmunoGenomicsAugust 15th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
